Vendor review
BeiBangAn reviews
BeiBangAn reviews from 71 independent lab tests (Retatrutide, Tirzepatide and GHK-Cu): grade A, purity and fill accuracy. Is BeiBangAn legit? See what its vials showed.
What the lab tests show
71 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Aug 21, 2026 | Retatrutide | 99.8 % | 32.2 mg of 30 mg (7 %) | Pass | View |
| Aug 18, 2026 | Semaglutide | 99.9 % | 33.3 mg of 30 mg (11 %) | Pass | View |
| Aug 18, 2026 | Tirzepatide | 99.9 % | 56.9 mg of 50 mg (14 %) | Pass | View |
| Aug 18, 2026 | Retatrutide | 99.9 % | 51.7 mg of 50 mg (3 %) | Pass | View |
| Aug 12, 2026 | Retatrutide | 99.9 % | 22.3 mg of 30 mg (-26 %) | Pass | View |
| Aug 4, 2026 | Tirzepatide | 99.9 % | 34.5 mg of 40 mg (-14 %) | Pass | View |
| Jul 21, 2026 | Tirzepatide | 99.9 % | 35.8 mg of 30 mg (19 %) | Pass | View |
| Jul 13, 2026 | Tirzepatide | 99.9 % | 26.1 mg of 30 mg (-13 %) | Pass | View |
| Jul 13, 2026 | GHK-Cu | 99.9 % | 52 mg of 50 mg (4 %) | Pass | View |
| Jul 10, 2026 | Retatrutide | 99.7 % | 15.1 mg of 15 mg (1 %) | Pass | View |
| Jun 26, 2026 | Retatrutide | 99.8 % | 19.3 mg of 20 mg (-3 %) | Pass | View |
| May 27, 2026 | Retatrutide | 80.7 % | 11.6 mg of 15 mg (-23 %) | Pass | View |
| May 11, 2026 | Retatrutide | 10 mg | View | ||
| May 8, 2026 | Retatrutide | 99.7 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Apr 28, 2026 | Retatrutide | 99.9 % | 20 mg of 20 mg (0 %) | Pass | View |
| Mar 18, 2026 | Retatrutide | 99.9 % | 19.6 mg of 20 mg (-2 %) | Pass | View |
| Mar 13, 2026 | Retatrutide | 99.8 % | 64.3 mg of 60 mg (7 %) | Pass | View |
| Mar 13, 2026 | Retatrutide | 99.8 % | 21.1 mg of 20 mg (6 %) | Pass | View |
| Mar 12, 2026 | GHK-Cu | 99.8 % | 43.9 mg of 50 mg (-12 %) | Pass | View |
| Mar 1, 2026 | Retatrutide | 99.8 % | 30.7 mg of 30 mg (2 %) | Pass | View |
| Mar 1, 2026 | Retatrutide | 99.8 % | 29.4 mg of 30 mg (-2 %) | Pass | View |
| Feb 26, 2026 | Retatrutide | 99.9 % | 17.3 mg of 20 mg (-14 %) | Pass | View |
| Feb 26, 2026 | Retatrutide | 99.9 % | 19.5 mg of 20 mg (-3 %) | Pass | View |
| Feb 26, 2026 | Tirzepatide | 99.8 % | 60 mg of 60 mg (0 %) | Pass | View |
| Feb 26, 2026 | Tirzepatide | 94.16 % | 31.6 mg of 30 mg (5 %) | Pass | View |
| Feb 20, 2026 | Retatrutide | 99.8 % | 27.2 mg of 20 mg (36 %) | Pass | View |
| Feb 20, 2026 | Retatrutide | 99.8 % | 30 mg of 30 mg (0 %) | Pass | View |
| Feb 20, 2026 | Tirzepatide | 99.8 % | 27.1 mg of 60 mg (-55 %) | Pass | View |
| Feb 20, 2026 | Tirzepatide | 99.9 % | 32.4 mg of 30 mg (8 %) | Pass | View |
| Feb 15, 2026 | Tirzepatide | 99.8 % | 24.5 mg of 20 mg (23 %) | Pass | View |
| Feb 15, 2026 | BPC-157 | 99.6 % | 11.4 mg of 10 mg (14 %) | Pass | View |
| Feb 4, 2026 | Tirzepatide | 99.9 % | 64.8 mg of 60 mg (8 %) | Pass | View |
| Feb 4, 2026 | GHK-Cu | 99.85 % | 62.1 mg of 100 mg (-38 %) | Pass | View |
| Jan 19, 2026 | Tirzepatide | 99.31 % | 31.6 mg of 30 mg (5 %) | Pass | View |
| Jan 15, 2026 | Retatrutide | 99.8 % | 27.7 mg of 30 mg (-8 %) | Pass | View |
| Jan 9, 2026 | Semaglutide | 98.75 % | 20.5 mg of 20 mg (2 %) | Pass | View |
| Jan 7, 2026 | Retatrutide | 99.44 % | 36.7 mg of 40 mg (-8 %) | Pass | View |
| Jan 7, 2026 | Retatrutide | 99.8 % | 55.1 mg of 60 mg (-8 %) | Pass | View |
| Jan 6, 2026 | GHK-Cu | 99.88 % | 48.3 mg of 50 mg (-3 %) | Pass | View |
| Jan 6, 2026 | GHK-Cu | 99.75 % | 110 mg of 100 mg (10 %) | Pass | View |
| Jan 1, 2026 | Retatrutide | 99.4 % | 9.5 mg of 10 mg (-5 %) | Pass | View |
| Dec 29, 2025 | BPC-157 | 98.5 % | 10.3 mg of 10 mg (3 %) | Pass | View |
| Dec 29, 2025 | PT-141 | 99.6 % | 13.8 mg of 10 mg (38 %) | Pass | View |
| Dec 29, 2025 | Retatrutide | 99.95 % | 21.2 mg of 20 mg (6 %) | Pass | View |
| Dec 29, 2025 | Tirzepatide | 99.95 % | 31.2 mg of 30 mg (4 %) | Pass | View |
| Dec 29, 2025 | Tirzepatide | 99.8 % | 32.4 mg of 30 mg (8 %) | Pass | View |
| Dec 18, 2025 | Semaglutide | 99.7 % | 35.2 mg of 30 mg (17 %) | Pass | View |
| Dec 18, 2025 | Retatrutide | 99.8 % | 33.3 mg of 30 mg (11 %) | Pass | View |
| Dec 18, 2025 | Tirzepatide | 99.8 % | 34.1 mg of 30 mg (14 %) | Pass | View |
| Dec 18, 2025 | Tirzepatide | 99.8 % | 34.8 mg of 30 mg (16 %) | Pass | View |
| Dec 18, 2025 | Tirzepatide | 99.7 % | 23.2 mg of 60 mg (-61 %) | Pass | View |
| Dec 17, 2025 | PT-141 | 99.9 % | 10.7 mg of 10 mg (7 %) | Pass | View |
| Dec 17, 2025 | Tirzepatide | 99.7 % | 45.5 mg of 50 mg (-9 %) | Pass | View |
| Dec 17, 2025 | BPC-157 | 99.95 % | 10.3 mg of 10 mg (3 %) | Pass | View |
| Dec 17, 2025 | Semaglutide | 99.95 % | 11.4 mg of 10 mg (14 %) | Pass | View |
| Dec 16, 2025 | Retatrutide | 99.7 % | 21.5 mg of 20 mg (8 %) | Pass | View |
| Dec 11, 2025 | Retatrutide | 99.88 % | 38.1 mg of 40 mg (-5 %) | Pass | View |
| Dec 11, 2025 | Tirzepatide | 99.95 % | 42.3 mg of 40 mg (6 %) | Pass | View |
| Dec 11, 2025 | BPC-157 | 99.77 % | 8.96 mg of 10 mg (-10 %) | Pass | View |
| Dec 11, 2025 | Tesamorelin | 99.86 % | 15 mg of 10 mg (50 %) | Pass | View |
What BeiBangAn sells
No current listings on record.
About BeiBangAn
Telegram Vendor